Company Search:
Advanced Search
Sponsored Links
GlaxoSmithKline plc - ADR Company Snapshot
GlaxoSmithKline plc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other companies in this sector in the United States: Sanofi S.A. (2015 sales of $38.45 billion of which 85% was Pharmaceuticals), Pfizer Inc. ($48.85 billion of which 44% was Operating Segment-Global Established Pha), and Merck & Co. , Inc. ($39.50 billion of which 88% was Merck Pharmaceutical).

Sales Analysis. During the year ended December of 2015, sales at GlaxoSmithKline plc were $36.48 billion. This is a decrease of 3.7% versus 2014, when the company's sales were $37.87 billion.
  Stock Performance Chart for GlaxoSmithKline plc - ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 39.22
(Figures in U.S. Dollars)
1 Week -0.4%   13 Weeks 1.8%  
4 Weeks -5.9%   52 Weeks 0.8%  
GlaxoSmithKline plc - ADR Key Data:
  Ticker: GSK Country: United States
  Exchanges: NYSE FRA MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 36,480,661,160
(Year Ending Jan 2016).
Employees: 101,192
  Currency: U.S. Dollars Market Cap: 95,613,562,923
  Fiscal Yr Ends: December Shares Outstanding: 2,437,877,688
  Share Type: Ordinary Closely Held Shares: 24,389,859
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.